Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Jiangsu Nanfang Medical Co's FCF Margin % or its related term are showing as below:
SHSE:603880'
s FCF Margin % Range Over the Past 10 Years
Min: -56.12 Med: -0.94 Max: 11.51
Current: 11.51
During the past 13 years, the highest FCF Margin % of Jiangsu Nanfang Medical Co was 11.51%. The lowest was -56.12%. And the median was -0.94%.
SHSE:603880's FCF Margin % is ranked better than 77.67% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.56
vs SHSE:603880: 11.51
Jiangsu Nanfang Medical Co FCF Margin % Related Terms
Jiangsu Nanfang Medical Co FCF Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:603880 vs ISRG, BDX, MDLN: FCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, Jiangsu Nanfang Medical Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jiangsu Nanfang Medical Co FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Jiangsu Nanfang Medical Co's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Jiangsu Nanfang Medical Co's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jiangsu Nanfang Medical Co (SHSE:603880) has a FCF Margin % of 23.32% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Jiangsu Nanfang Medical Co and its competitors. According to the industry distribution chart, Jiangsu Nanfang Medical Co ranks #182 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 22.3%.
Is Jiangsu Nanfang Medical Co's FCF Margin % too high?
Jiangsu Nanfang Medical Co's current FCF Margin % is 23.32%. Based on the distribution chart, Jiangsu Nanfang Medical Co ranks #182 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Jiangsu Nanfang Medical Co has a GF Score™ of 50/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Jiangsu Nanfang Medical Co's FCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Jiangsu Nanfang Medical Co ranks #182 out of 815 companies for FCF Margin %. This places Jiangsu Nanfang Medical Co in the top 22% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Jiangsu Nanfang Medical Co and its competitors. Jiangsu Nanfang Medical Co's current FCF Margin % is 23.32%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jiangsu Nanfang Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Jiangsu Nanfang Medical Co (SHSE:603880) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥4.71, compared to a current price of ¥6.37 — trading 35.2% above its estimated fair value. The current FCF Margin % is 23.32%. Jiangsu Nanfang Medical Co's overall GF Score™ is 50/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Jiangsu Nanfang Medical Co (SHSE:603880), the current FCF Margin % is 23.32% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jiangsu Nanfang Medical Co (SHSE:603880) Overvalued in 2026?
Based on GuruFocus' analysis, Jiangsu Nanfang Medical Co stock appears to be overvalued.
The current stock price of ¥6.37 is trading 35.2% above its estimated GF Value™ of ¥4.71.
GuruFocus considers Jiangsu Nanfang Medical Co to be Significantly Overvalued.
Key valuation signals for SHSE:603880:
FCF Margin %: 23.32%
GF Value™: ¥4.71 vs. price of ¥6.37 (35.2% above fair value)
No single metric tells the full story. See the SHSE:603880 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jiangsu Nanfang Medical Co Ltd is a domestic adhesive dressing production enterprise that integrates research and development, production, and sales. It produces a band-aid in China. The company is focused on the development of self-owned brand products such as first-aid kits, sports protection products, and care products on the basis of the original series of Miaoshou medical dressings.
50GF Score
Get the complete analysis for SHSE:603880
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603880 has been successfully added to your 
